Ranunculin, Protoanemonin, and Anemonin : Pharmacological and Chemical Perspectives
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Ranunculin, a glucoside, serves as a chemotaxonomic marker in Ranunculaceae plants. When these plants are damaged, an enzyme β-glucosidase triggers the conversion of ranunculin into protoanemonin through hydrolysis. Subsequently, protoanemonin undergoes cyclodimerization to form anemonin. The inherent instability of ranunculin and the rapid dimerization of protoanemonin render them unsuitable for use in biological assays. Conversely, anemonin stands out as the optimal molecule for bioassays and demonstrates diverse biological properties, including anti-inflammatory, anti-infective, and anti-oxidant effects. Among these, anemonin exhibits the greatest promise in addressing conditions such as arthritis, cerebral ischemia, and ulcerative colitis. Its potential medical uses are enhanced by its capacity to inhibit nitric oxide synthesis and successfully counteract lipopolysaccharide-induced inflammation. This review describes the chemistry and biological properties of anemonin and its precursors, including discussions on extraction, isolation, synthesis, and investigations into bioactivity and pharmacokinetics.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Current medicinal chemistry - (2024) vom: 28. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sirak, Betelhem [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biological activities |
---|
Anmerkungen: |
Date Revised 01.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0109298673294080240221115830 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369150082 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369150082 | ||
003 | DE-627 | ||
005 | 20240301233344.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240301s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0109298673294080240221115830 |2 doi | |
028 | 5 | 2 | |a pubmed24n1313.xml |
035 | |a (DE-627)NLM369150082 | ||
035 | |a (NLM)38425112 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sirak, Betelhem |e verfasserin |4 aut | |
245 | 1 | 0 | |a Ranunculin, Protoanemonin, and Anemonin |b Pharmacological and Chemical Perspectives |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Ranunculin, a glucoside, serves as a chemotaxonomic marker in Ranunculaceae plants. When these plants are damaged, an enzyme β-glucosidase triggers the conversion of ranunculin into protoanemonin through hydrolysis. Subsequently, protoanemonin undergoes cyclodimerization to form anemonin. The inherent instability of ranunculin and the rapid dimerization of protoanemonin render them unsuitable for use in biological assays. Conversely, anemonin stands out as the optimal molecule for bioassays and demonstrates diverse biological properties, including anti-inflammatory, anti-infective, and anti-oxidant effects. Among these, anemonin exhibits the greatest promise in addressing conditions such as arthritis, cerebral ischemia, and ulcerative colitis. Its potential medical uses are enhanced by its capacity to inhibit nitric oxide synthesis and successfully counteract lipopolysaccharide-induced inflammation. This review describes the chemistry and biological properties of anemonin and its precursors, including discussions on extraction, isolation, synthesis, and investigations into bioactivity and pharmacokinetics | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Ranunculaceae | |
650 | 4 | |a biological activities | |
650 | 4 | |a medicinal plants | |
650 | 4 | |a natural products | |
650 | 4 | |a review. | |
700 | 1 | |a Aragaw, Misgana |e verfasserin |4 aut | |
700 | 1 | |a Tadesse, Solomon |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g (2024) vom: 28. Feb. |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:28 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0109298673294080240221115830 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 28 |c 02 |